0001231919-21-000017.txt : 20210212 0001231919-21-000017.hdr.sgml : 20210212 20210212080343 ACCESSION NUMBER: 0001231919-21-000017 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389278 FILM NUMBER: 21622885 BUSINESS ADDRESS: STREET 1: 4260 U.S. ROUTE 1 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 4260 U.S. ROUTE 1 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 D 1 primary_doc.xml X0708 D LIVE 0001649989 Outlook Therapeutics, Inc. 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 6096193990 DELAWARE Oncobiologics, Inc. Corporation true Randy Thurman c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Yezan Haddadin c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Kurt J. Hilzinger c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Lawrence A. Kenyon c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Director Faisal G. Sukhtian c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Andong Huang c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Gerd Auffarth c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Julian Gangolli c/o Outlook Therapeutics, Inc. 4260 U.S. Route 1 Monmouth Junction NJ NEW JERSEY 08852 Director Biotechnology Decline to Disclose 06b false 2021-02-03 false true false 0 4013627 4013627 0 false 2 0 0 0 false Outlook Therapeutics, Inc. /s/ Lawrence Kenyon Lawrence Kenyon Chief Executive Officer 2021-02-11